About Masoud Dara, MD
Dr. Masoud Dara is the Team Leader of the Tuberculosis Programme in the Division of Communicable Diseases, Health Security & Environment at WHO Europe.
Dr. Masoud Dara is a physician and public health expert from Belgium. In addition to his medical degree, he has accomplished several courses and postgraduate studies including courses at London School of Hygiene and Tropical Medicine and Harvard School of Public Health. Dr. Dara’s professional career began as a clinician responsible for diagnosis and treating tuberculosis and implementing DOTS in rural and urban areas of Iran. Since 1998, Dr. Dara has been working with multiple national and international organizations implementing TB control programmes. He has worked as the Médecins Sans Frontières programme manager and medical coordinator of several TB control projects in Central Asia from 1998 to 2001. From 2001-2003 Dr. Dara worked as a WHO Medical Officer in the Russian Federation providing technical assistance to national health authorities and TB control services across the country. From 2003-2010, Dr. Dara worked as a senior consultant of KNCV Tuberculosis Foundation in different countries mainly in the fields of MDR-TB, TB/HIV and TB-IC. Since 2008 Dr. Dara has been appointed as the Chair of scientific working group of TB control in prisons of International Union Against Tuberculosis and Lung Diseases. From 2004 to 2010, he has provided technical assistance to different countries as a GLC consultant and MDR-TB and TB-IC trainer. Since September 2010, Dr. Dara has joined WHO Regional Office for Europe coordinating WHO technical assistance to the Member States in prevention and control of drug resistant TB and since 2011, he is team leader and manager of WHO/Europe TB and M/XDR-TB programme. Dr. Dara speaks English, French, Russian, Persian and Dutch.
Role(s) / Profession(s)
- Medical Officer, Director
WHO Europe - EURO
Website: http://www.euro.who.int/en/home Type: International Organization/Agency Country: Denmark About: WHO is the authority responsible for public health within the United Nations system. The WHO Regional Office for Europe (WHO/Europe) is one of WHO’s six regional offices around the world. It serves the WHO European Region, which comprises 53 countries, covering a vast geographical region from the Atlantic to the Pacific oceans.
Masoud Dara, MD started a discussion "Join us for a live twitter chat 22 March 10-11 AM CET". in the MDR-TB Treatment & Prevention community.
Dear colleagues, Join us on Twitter for live #TBchat 18-03-2013 Experts from WHO/Europe and the European Centre for Disease Prevention and Control (ECDC) will answer questions on tuberculosis (TB) during a live Twitter chat on Friday, 22 March 2013, 10.00-11.00 UTC/GMT (11:00-12:00 CET, Copenhagen time). The chat, using the hashtag ...
Dear colleagues, For those of you who have not watched it yet, here is the link to a TV interview on substandard TB drugs and drug resistant TB. http://www.youtube.com/watch?v=sGhmy_1Btc0&feature=share All the best, Masoud Dr Masoud Dara Programme Manager / Medical Officer Tuberculosis and M/XDR-TB Programme Division of Communicable Diseases, Health ...
Masoud Dara, MD started a discussion "WHO/Europe vaccancy for a Medical Officer on TB and M/XDR-TB in Uzbekistan, deadline for application 16 February 2013". in the MDR-TB Treatment & Prevention community.
Dear colleagues, Please distribute as you deem appropriate. World Health Organization is recruiting a TB and M/XDR-TB Medical Officer in Uzbekistan. https://erecruit.who.int/public/hrd-cl-vac-view.asp?o_c=1000&jobinfo_uid_c=27063&vaclng=en Best regards, Masoud
Dear colleagues, Please keep continuing introducing yourself in the previous thread. It is a real pleasure to know our members. On another note, please find WHO information note on Bedaquiline. http://www.who.int/tb/information_note_bedaquiline/en/index.html You may also find the Wikipedia link useful http://en.wikipedia.org/wiki/Bedaquiline Is your programme using new medicines? If so which one, ...
Copenhagen 8 January 2013, Dear colleagues and friends of GHD online DR-TB community, Happy New Year, 2012 was a successful year with significant progress in scaling up rapid diagnosis and concrete steps in achieving a potentially better treatment of MDR-TB. I hope 2013 would bring us more success. Our community ...